Streptococcus pneumoniae remains a major cause of childhood morbidity and mortality. At least 1 million children die of pneumococcal infections each year, mostly in developing countries. 1 In addition, pneumococcal resistance to antibiotics such as penicillin is an increasing problem worldwide. The polysaccharide capsule is the main virulence factor of the pneumococcus; 90 diVerent capsular polysaccharide serotypes have been described. 2 The prevalence of individual serotypes varies among diVerent age groups and diVerent geographical areas, and changes over time. In this review, we discuss the current epidemiology of paediatric pneumococcal disease in Europe and the potential role of new pneumococcal conjugate vaccines. In a meta-analysis of bacterial meningitis outcomes in developed countries, 13 S pneumoniae caused more deaths and neurological sequelae than either Haemophilus influenzae or Neisseria meningitidis. Of the children with pneumococcal meningitis reviewed in the meta-analysis, 17% developed mental retardation, 14% a seizure disorder, 28% deafness (16% profound or severe), and 12% spasticity or paresis. The case fatality rate was 15%. There is little information about outcomes of paediatric IPD in the UK. Hospital admission rates in England for pneumococcal meningitis and septicaemia, based on ICD 10 codes, were 1.9 and 1.2 respectively per 100 000 children under 15 years in 1997, with a mean duration of stay of 14 days in the former and seven days in the latter group.
Pneumococcal epidemiology3 In 1996-98, 16% of paediatric meningitis cases and 9% of other paediatric IPD cases in England and Wales were reported to have died of their infection.
3Unfortunately outcome was only reported in 28% of the IPD cases, potentially biasing the case fatality. Indeed, in a recent retrospective case note review of children under 5 years, identified by enhanced surveillance of IPD in the Oxford region, mortality was only 1%.14 There was, however, significant morbidity: 7% of children developed persisting neurological disability and the mean duration of hospital stay was eight days.
PNEUMONIAAccurate epidemiological data about childhood pneumonia are diYcult to obtain as a result of diYculties with diagnosis and empirical antibiotic treatment. Djuretic et al studied hospital admissions in England in 1994-95 in children aged less than 5 years diagnosed with pneumonia.15 Admission rates for "lobar pneumonia", "bronchopneumonia", and "pneumonia, unspecified", based on ICD 9 codes, were 104, 36, and 85 per 100 000 respectively (225 per 100 000 for all three codes); mean duration of stay was four days for each diagnosis.A retrospective case note review was also performed. There were lobar/focal changes on chest x ray (CXR) in 79% of cases, although only 46% were coded as "lobar pneumonia". Only half the cases that met the authors' definitions of "definite" pneumococcal pneumonia (pneumococcus in blood culture) or "likely" pneumococcal pneumonia (lobar/focal consolidation on CXR and white cell count of at least 15 × 10 9 ...